Shanghai Chest Hospital: Lung Neoplasms trials
The registry lists 59 Lung Neoplasms studies with Shanghai Chest Hospital as lead sponsor. 33 are open to participants now and 0 have results posted.
Phase 1 6Phase 2 13Phase 3 3Phase 4 2No phase 39(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Pulsed Field Ablation for the Treatment of Malignant Lung TumorsNot yet recruitingNCT07889297Not applicable
- 5G-Enabled Remote Robotic-Assisted Bronchoscopy-Guided Cryoablation for Pulmonary MalignanciesNot yet recruitingNCT07830095Not applicable
- 18G Ultrafine Cryoablation Needle for Coaxial Biopsy and Cryoablation of Pulmonary NodulesNot yet recruitingNCT07806981Not applicable
- Label-free Femtosecond Laser Imaging Combined With the Fast Lung Artificial Intelligence Model for Rapid Intraoperative Diagnosis of Lung Surgical Specimens: A Multicentre, Prospective, Parallel-workflow, Non-inferiority Study.RecruitingNCT07681245
- Septum-guided Segmentectomy for Deep Early-stage Lung Cancer (SGS2512)RecruitingNCT07564557Not applicable
- Vebreltinib Plus Chemotherapy as First-line Treatment for MET-overexpressing NSCLCNot yet recruitingNCT07549061Phase 2
- SGLT2 Inhibitors and Survival in Lung Cancer Patients With DiabetesNot yet recruitingNCT07272057Not applicable
- Sleeve Lobectomy Following Neoadjuvant Therapy in NSCLCRecruitingNCT07135856
- Novel Thin Bronchoscope Versus Ultrathin Bronchoscope for the Diagnosis of Peripheral Pulmonary NodulesNot yet recruitingNCT07135297Not applicable
- Assessment the Effectiveness of BTVA in COPD and Ablation in Pulmonary Nodules by Pulmonary MRIRecruitingNCT07045532
- MWA With or Without Furmonertinib for Early-Stage Non-Small Cell Lung CancerNot yet recruitingNCT06969781Not applicable
- Transbronchial MWA for Pulmonary TumorsRecruitingNCT06969014Not applicable
- Real-World Assessment of Therapeutic Strategies and Survival Outcomes Following First-Line Tislelizumab Therapy in Advanced Non-Small Cell Lung CancerEnrolling by invitationNCT06962449
- A Multicenter, Single-arm Phase II Study to Evaluate the Efficacy and Safety of Fulzerasib (IBI351) in Combination With Ivonescimab (AK-112) in First-line Treatment of Advanced or Metastatic Non-small Cell Lung Cancer Patients With KRAS G12C MutationNot yet recruitingNCT06936644Phase 2
- Biomarkers for Clinical Classification and Outcomes of Immune Checkpoint Inhibitor-Related-Related Myocarditis in Lung CancerRecruitingNCT06818149
- Glycoprotein in Immunotherapy Response and Efficacy Prediction of Lung CancerRecruitingNCT06730503
- Efficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer Using a Combination Therapy of Trilaciclib, Envafolimab, Etoposide, and CarboplatinRecruitingNCT06698965Phase 2
- A Single-Arm, Phase Ⅰb Study of Golidocitinib Combined With Anti-PD-1 for the Treatment of Previously Treated NSCLCNot yet recruitingNCT06690671Phase 1/2
- Neoadjuvant Chemotherapy Sequentially Combined with Sintilimab in Resectable EGFR-Mutant NSCLCNot yet recruitingNCT06688656Phase 2
- Intrathecal Injection Pemetrexed And Bevacizumab in Patients With Leptomeningeal Metastases in NSCLCRecruitingNCT06663306Phase 1
- Perioperative Tislelizumab for Resectable II-IIIB(N2) KRAS-mutated Nonsquamous Non-small Cell Lung CancerRecruitingNCT06659042Phase 2
- Cryoablation with or Without Serplulimab in Treating Patients with Stage I-IIA Non-small Cell Lung CancerNot yet recruitingNCT06580665Not applicable
- Transthoracic vs Transbronchial Radiofrequency Ablation for Lung CancerRecruitingNCT06503744Not applicable
- Improving Patient-reported Outcomes After Lung Cancer Surgery With Mobile Internet PlatformRecruitingNCT06483295Not applicable
- Efficacy and Safety of Combination Therapy of Sintilimab and Chemotherapy With Cryoablation in NSCLCNot yet recruitingNCT06483009Phase 4
- Trametinib Plus Anlotinib Combined With Tislelizumab in KRAS-mutant NSCLCNot yet recruitingNCT06456138Phase 1/2
- Efficacy and Safety of Multimode Thermal Therapy in the Treatment of Early Peripheral Lung CancerNot yet recruitingNCT06453889Not applicable
- Predicting Non-small Cell Lung Cancer (NSCLC) Lymph Node Metastasis: Integrating Circulating Tumor DNA (ctDNA) Mutation/ Methylation Profiling With Positron Emission Tomography-computed Tomography (PET-CT) ScanRecruitingNCT06358222
- Association of Psychological Distress in Patients With Lung CancerRecruitingNCT06218901
- China Lung Cancer Screening (CLUS) Study Version 3.0RecruitingNCT05494021Not applicable
- First-line Treatment With Dacomitinib Plus Anlotinib for Patients With Advanced NSCLC With EGFR 21L858R MutationsRecruitingNCT05271916Phase 1/2
- Analysis of Drug Resistance in Immune Checkpoint Inhibitors of Non-small Cell Lung CancerRecruitingNCT04977791
- ENB-guided Ablation Therapy Combined With VATS in the Treatment of MPLCRecruitingNCT04730453
- Augmented Reality Assisted Lung Nodule Localization: a Multicentered, Prospective, Randomly Controlled, Non-inferiority TrialCompletedNCT06548451Not applicable
- Sintilimab Combined With Anlotinib for Perioperative Non-small Cell Lung Cancer Based on MRD EvaluationStatus unknownNCT05460195Phase 2
- To Evaluate the Efficacy of Durvalumab + Anlotinib in Terms of OS and PFS.Active, not recruitingNCT04985851Not applicable
- Trametinib Plus Anlotinib in Non-G12C KRAS-Mutant NSCLC PatientsCompletedNCT04967079Phase 1
- To Evaluate the Efficacy of Afatinib in the Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer With NRG1 FusionStatus unknownNCT04814056Phase 4
- Cardiac Adverse Reactions Related to Immune Checkpoint Inhibitor in NSCLC PatientsStatus unknownNCT04473703
- cfDNA Methylation Assay for Clinical Evaluation of Patients With Stage IA Lung Cancer After Ablation OperationStatus unknownNCT04413656Not applicable
- Pyrotinib Plus Thalidomide in Advanced NSCLC Patients Harboring HER2 Exon 20 InsertionsStatus unknownNCT04382300Phase 2
- Neoadjuvant Therapy in Resectable Non-Small Cell Lung Cancer Stages IIB-IIIBStatus unknownNCT04197076
- NGS-based Large-panel in Targeted Drug Delivery and Immunotherapy of Lung CancerStatus unknownNCT04159337
- ENB Guided MWA for Early-stage Peripheral Lung CancerStatus unknownNCT04005157Not applicable
- China Lung Cancer Screening (CLUS) Study Version 2.0Status unknownNCT03975504Not applicable
- Electromagnetic Navigation Versus CT Guided TTNA in the Diagnosis of Early Peripheral Lung CancerStatus unknownNCT03802266Not applicable
- First-line Combination Treatment Based on AnlotinibStatus unknownNCT03628521Phase 1
- Analysis of Re-biopsy Specimens in Advanced NSCLC With Acquired Resistance of EGFR-TKI Targeted TherapyCompletedNCT03309462Not applicable
- ENB Guided RFA for Early-stage Peripheral Lung CancerStatus unknownNCT03009630Not applicable
- To Evaluate the Role of Postoperative Radiotherapy in Patients With IIIA(N2) Non-Small Cell Lung CancerStatus unknownNCT02977169Phase 2
- To Evaluate the Optimal Timing of Postoperative Radiotherapy in Patients With IIIA(N2) Non-Small Cell Lung CancerTerminatedNCT02974426Phase 3
- Transbronchial Ablation for Peripheral Lung TumorStatus unknownNCT02972177Not applicable
- Precision Diagnosis for Intraoperative Frozen Section of Early Stage Lung CancerStatus unknownNCT02941003Not applicable
- 18F-FDG Metabolism Imaging Monitoring Non-small Cell Lung Cancer Curative Effect of Chemotherapy Multicenter Clinical StudyStatus unknownNCT02938546Phase 3
- Precision Diagnosis and Therapy for Early Stage Lung CancerStatus unknownNCT02936804Not applicable
- Early Stage Lung Cancer Screening With Low-dose Computed TomographicStatus unknownNCT02898441Not applicable
- Cellular Immunotherapy Synergize Chemotherapy in Patients With Stage IV NSCLCStatus unknownNCT02669719Phase 2
- Percutaneous Cryoablation Peripheral Lung CancerStatus unknownNCT02665390Not applicable
- Comparator-Controlled Study for EGFR(+) Patients With Multiple BMs From NSCLC (BROKE) (EGFR-epidermal Growth Factor Receptor;BM-brain Metastases)Status unknownNCT02338011Phase 2/3